Hemodynamic Parameters Assessment; Invasive Versus Noninvasive

Launched by ASSIUT UNIVERSITY · Jan 8, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how well a noninvasive method of measuring heart function works compared to traditional invasive techniques in critically ill patients in a respiratory intensive care unit (ICU). The goal is to see if the noninvasive method, which does not require inserting a catheter into the body, can accurately assess heart parameters like cardiac output, which measures how well the heart is pumping blood.

To participate in this trial, patients need to be 18 years or older and currently receiving care in a respiratory ICU, regardless of whether they are experiencing blood flow issues. However, individuals with certain conditions, such as active infections at the catheter insertion site or serious heart rhythm problems, will not be eligible. If you or a loved one meets the criteria and decides to join, you can expect to undergo tests that compare these two methods of heart assessment, helping researchers understand which is more effective for critically ill patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients who are 18 years old or more.
• • 2. Critically ill patient in respiratory ICU unit with or without hemodynamic instability.
• Exclusion Criteria:
• • 1. Presence of active infection at the site of insertion of PCA.
• • 2. Presence of coagulopathy or severe thrombocytopenia.
• • 3. Presence of cardiac arrhythmia or left bundle branch block.
• • 4. Newly inserted pacemaker of the heart.
• • 5. Lack of consent.